Healthcare -
Biotechnology - NASDAQ - US
$ 2.28
-3.8 %
$ 60.5 M
Market Cap
-2.13
P/E
GANX - COST OF REVENUE
Cost of Revenue GANX - Gain Therapeutics, Inc.
80.4 K
LAST VALUE
-89.41%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR